IP Library Granted Patent US 7,560,596
Granted Patent B2
US 7,560,596 · App. 11/328,426 · Granted Jul 14, 2009

Transition-metal-catalyzed carbon-nitrogen and carbon-carbon bond-forming reactions

Assignee: Massachusetts Institute of Technology
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,560,596
App. No.
11/328,426
Granted
Jul 14, 2009
Kind
B2
Abstract

One aspect of the present invention relates to ligands for transition metals. A second aspect of the present invention relates to the use of catalysts comprising these ligands in various transition-metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions. The subject methods provide improvements in many features of the transition-metal-catalyzed reactions, including the range of suitable substrates, number of catalyst turnovers, reaction conditions, and efficiency. For example, improvements have been realized in transition metal-catalyzed: aryl amination reactions; aryl amidation reactions; Suzuki couplings; and Sonogashira couplings. In certain embodiments, the invention relates to catalysts and methods of using them that operate in aqueous solvent systems.

Claims (47)

1. A ligand represented by structure L:

wherein

R is selected independently for each occurrence from the group consisting of alkyl, cycloalkyl, aryl, heteroaryl, aralkyl, heteroaralkyl, and —(CH 2 ) m —R 80 ;

R 1 is selected independently for each occurrence from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —OR 8 , —N(R 8 ) 2 , —Si(R 8 ) 3 , and —(CH 2 ) m —R 80 ;

R 2 is selected from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —OR 8 , —N(R 8 ) 2 , —Si(R 8 ) 3 , and —(CH 2 ) m —R 80 ;

R 3 is selected from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —OR 8 , —N(R 8 ) 2 , —Si(R 8 ) 3 , —R 7 , and —(CH 2 ) m —R 80 ;

R 4 is selected from the group consisting of halogen, alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —OR 8 , —N(R 8 ) 2 , —Si(R 8 ) 3 , —R 7 , and —(CH 2 ) m —R 80 ;

R 5 is selected from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —OR 8 , —N(R 8 ) 2 , —Si(R 8 ) 3 , —R 7 , and —(CH 2 ) m —R 80 ;

R 6 is selected from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —OR 8 , —N(R 8 ) 2 , —Si(R 8 ) 3 , and —(CH 2 ) m —R 80 ;

R 7 is selected independently for each occurrence from the group consisting of —C(O)OM, —C(O)SM, —C(S)SM, —C(NR 8 )OM, —C(NR 8 )SM, —S(O)OM, —S(O)SM, —S(O) 2 OM, —S(O) 2 SM, —P(O)(OM) 2 , —P(O)(OR 8 )OM, —P(O)(OR 8 )NR 8 M, —P(O)(OR 8 )SM, —N(R 8 ) 3 M, —P(R 8 ) 3 M, —P(OR 8 ) 3 M and —N(R 8 )C(NR 8 R 8 )NR 8 R 8 M;

R 8 is selected independently for each occurrence from the group consisting of hydrogen, alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, aralkyl, and heteroaralkyl;

M is an alkali metal or an alkali earth metal;

R 80 represents an unsubstituted or substituted aryl, a cycloalkyl, a cycloalkenyl, a heterocycle, or a polycycle;

m is independently for each occurrence an integer in the range 0 to 8 inclusive; provided that at least one of R 3 , R 4 or R 5 is R 7 ; and

the ligand is achiral or, when chiral, is a single stereoisomer or a mixture of stereoisomers.

2. The ligand of claim 1 , wherein R is cyclohexyl; R 1 is hydrogen; and R 2 is alkyl or alkoxy.

3. The ligand of claim 1 , wherein R is cyclohexyl; R 1 is hydrogen; and R 3 is R 7 .

4. The ligand of claim 1 , wherein R is cyclohexyl; R 1 is hydrogen; R 4 is R 7 ; and R 3 and R 5 are hydrogen.

5. The ligand of claim 1 , wherein R is cyclohexyl; R 1 is hydrogen; R 2 and R 6 are selected independently from the group consisting of hydrogen, alkyl and alkoxy; and R 3 is R 7 .

6. The ligand of claim 1 , wherein R is cyclohexyl; R 1 is hydrogen; R 2 and R 6 are selected independently from the group consisting of hydrogen, alkyl and alkoxy; R 4 is R 7 ; and R 3 and R 5 are selected independently from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —OR 8 , —N(R 8 ) 2 , —Si(R 8 ) 3 , and —(CH 2 ) m —R 80 .

7. The ligand of claim 1 , wherein R is cyclohexyl; R 1 is hydrogen; R 2 and R 6 are selected independently from the group consisting of hydrogen, alkyl and alkoxy; R 4 is R 7 ; and R 3 and R 5 are hydrogen.

8. The ligand of claim 1 , wherein R is cyclohexyl; R 1 is hydrogen; R 2 and R 6 are methoxy; and R 3 is —S(O) 2 ONa.

9. The ligand of claim 1 , wherein R is cyclohexyl; R 1 is hydrogen; R 2 and R 6 are isopropyl; R 4 is —S(O) 2 ONa; and R 3 and R 5 are hydrogen.

10. A ligand represented by structure L:

wherein

R is selected independently for each occurrence from the group consisting of alkyl, cycloalkyl, aryl, heteroaryl, aralkyl, heteroaralkyl, and —(CH 2 ) m —R 80 ;

R 1 is selected independently for each occurrence from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —OR 8 , —N(R 8 ) 2 , —Si(R 8 ) 3 , and —(CH 2 ) m —R 80 ;

R 2 is selected from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —OR 8 , —N(R 8 ) 2 , —Si(R 8 ) 3 , and —(CH 2 ) m —R 80 ;

R 3 is selected from the group consisting of halogen, alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —OR 8 , —N(R 8 ) 2 , —Si(R 8 ) 3 , —R 7 , and —(CH 2 ) m —R 80 ;

R 4 is selected from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —OR 8 , —N(R 8 ) 2 , —Si(R 8 ) 3 , —R 7 , and —(CH 2 ) m —R 80 ;

R 5 is selected from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —OR 8 , —N(R 8 ) 2 , —Si(R 8 ) 3 , —R 7 , and —(CH 2 ) m —R 80 ;

R 6 is selected from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —OR 8 , —N(R 8 ) 2 , —Si(R 8 ) 3 , and —(CH 2 ) m —R 80 ;

R 7 is selected independently for each occurrence from the group consisting of —C(O)OM, —C(O)SM, —C(S)SM, —C(NR 8 )OM, —C(NR 8 )SM, —S(O)OM, —S(O)SM, —S(O) 2 OM, —S(O) 2 SM, —P(O)(OM) 2 , —P(O)(OR 8 )OM, —P(O)(OR 8 )NR 8 M, —P(O)(OR 8 )SM, —N(R 8 ) 3 M, —P(R 8 ) 3 M, —P(OR 8 ) 3 M and —N(R 8 )C(NR 8 R 8 )NR 8 R 8 M;

R 8 is selected independently for each occurrence from the group consisting of hydrogen, alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, aralkyl, and heteroaralkyl;

M is an alkali metal or an alkali earth metal;

R 80 represents an unsubstituted or substituted aryl, a cycloalkyl, a cycloalkenyl, a heterocycle, or a polycycle;

m is independently for each occurrence an integer in the range 0 to 8 inclusive;

provided that at least one of R 3 , R 4 or R 5 is R 7 ; and

the ligand is achiral or, when chiral, is a single stereoisomer or a mixture of stereoisomers.

11. The ligand of claim 10 , wherein R is cyclohexyl; R 1 is hydrogen; and R 2 is alkyl or alkoxy.

12. The ligand of claim 10 , wherein R is cyclohexyl; R 1 is hydrogen; R 2 is alkyl or alkoxy; and R 3 is R 7 .

13. The ligand of claim 10 , wherein R is cyclohexyl; R 1 is hydrogen; R 3 is R 7 ; and R 4 and R 5 are hydrogen.

14. The ligand of claim 10 , wherein R is cyclohexyl; R 1 is hydrogen; and R 3 is R 7 .

15. The ligand of claim 10 , wherein R is cyclohexyl; R 1 is hydrogen; R 2 and R 6 are selected independently from the group consisting of hydrogen, alkyl and alkoxy; R 3 is R 7 ; and R 4 and R 5 are selected independently from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, aralkyl, heteroaralkyl, —OR 8 , —N(R 8 ) 2 , —Si(R 8 ) 3 , and —(CH 2 ) m —R 80 .

16. The ligand of claim 10 , wherein R is cyclohexyl; R 1 is hydrogen; R 2 and R 6 are selected independently from the group consisting of hydrogen, alkyl and alkoxy; R 3 is R 7 ; and R 4 and R 5 are hydrogen.

17. The ligand of claim 10 , wherein R is cyclohexyl; R 1 is hydrogen; R 2 and R 6 are methoxy; R 3 is —S(O) 2 ONa; and R 4 and R 5 are hydrogen.

18. The ligand of claim 10 , wherein R is cyclohexyl; R 1 is hydrogen; R 2 and R 6 are isopropyl; and R 4 is —S(O) 2 ONa.

Assignments (2)
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Sep 9, 2008
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021503/0152 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2006
From: BUCHWALD, STEPHEN L.; ANDERSON, KEVIN W.
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 017520/0528 →
Continuity (2)
Provisional Application 6064277400 · Jan 10, 2005
Related Publication 20060173186A1 · Aug 3, 2006